
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
A roundup of the latest news and updates for patients with Renal Cell Carcinoma from CURE®.
Known as the most common form of kidney cancer in adults, renal cell carcinoma (RCC) has seen an influx of research in recent weeks. Here, CURE® looks back at some of the latest news and updates in the RCC space.
For more RCC coverage go






